These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 7296922

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical effects of labetalol on pheochromocytoma].
    Yoshinaga K, Arakawa K, Ando H, Iai F, Ikeda M.
    Horumon To Rinsho; 1983 Feb; 31(2):183-92. PubMed ID: 6340865
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Labetalol in the intraoperative control of pheochromocytoma].
    Janjić I, Luetić V.
    Lijec Vjesn; 1983 Feb; 105(7-8):304-6. PubMed ID: 6633151
    [No Abstract] [Full Text] [Related]

  • 10. Labetalol in the preoperative management of phaeochromocytoma.
    Russell WJ, Kaines AH, Hooper MJ, Frewin DB.
    Anaesth Intensive Care; 1982 May; 10(2):160-3. PubMed ID: 6125109
    [No Abstract] [Full Text] [Related]

  • 11. [Diazoxide vs. labetalol: a cross-over comparison of acute effects in hypertensive patients (author's transl)].
    Rumboldt Z, Bagatin J, Vidović A.
    Lijec Vjesn; 1980 Nov; 102(11):619-23. PubMed ID: 7024692
    [No Abstract] [Full Text] [Related]

  • 12. [Labetalol: a field study in essential hypertension (author's transl)].
    Greminger P, Minder F, Schärer HU.
    Schweiz Rundsch Med Prax; 1982 Feb 23; 71(8):332-6. PubMed ID: 7041108
    [No Abstract] [Full Text] [Related]

  • 13. Falsely high urinary catecholamines induced by labetalol.
    Kobayashi K, Miura Y, Tomioka H, Sakuma H, Adachi M, Abe K, Yoshinaga K.
    Tohoku J Exp Med; 1979 Jan 23; 127(1):63-9. PubMed ID: 760251
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of hypertension by labetalol (author's transl)].
    Sternon J, Melot C, Contu E.
    Rev Med Brux; 1980 Nov 23; 1(9):615-21. PubMed ID: 7455430
    [No Abstract] [Full Text] [Related]

  • 17. [Usefulness of combined captopril-labetalol treatment in resistant hypertension (author's transl)].
    El Matri A, Larabi MS, Kheder A, Belkahia C, Kechrid C, Ben Maiz H, Ben Ayed H.
    Nouv Presse Med; 1982 May 08; 11(21):1611-3. PubMed ID: 7048251
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Effects of alpha-and beta-adrenoceptor blocking agent (YM-09538) upon the clinical features of a patient with pheochromocytoma].
    Matsuura H, Koyama S, Tsuchioka Y, Yoshida M, Kurogane H.
    Horumon To Rinsho; 1982 Dec 08; 30(12):1439-46. PubMed ID: 6130862
    [No Abstract] [Full Text] [Related]

  • 20. [Drug therapy of pheochromocytoma].
    Coruzzi P, Novarini A.
    Ann Ital Med Int; 1989 Dec 08; 4(3):224-9. PubMed ID: 2577152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.